Search This Blog

Friday, July 12, 2019

Medigus Wins Order For Integrated Visualization Device

Medigus Ltd. MDGS 20.8% shares are up 57% after the company announced along with A.M. Surgical, Inc., the two companies received an order worth $650,000 for 1,400 units for its integrated visualization device. It’s the first “substantial commercial” order for the device.
Medigus will develop and manufacture an integrated visualization device based on its micro ScoutCam technology to work with Stratos, A.M.’s Surgical product for endoscopic procedures.
According to Medigus and A.M Surgical, the integrated device may have the potential of offering a higher level of surgical control and visualization during endoscopic carpal tunnel release for hundreds of thousands of procedures annually in the US.
“We are confident that the integration of our micro ScoutCam™ technology with the Stratos could provide surgeons with a powerful device to help their patients live with less pain,” said Liron Carmel, CEO of Medigus.

Johnson & Johnson started at Outperform by Credit Suisse

Target $156

Illumina cut to Underperform from Buy by B of A

https://www.benzinga.com/stock/ILMN/ratings

Centene target cut to $71 from $75 by Morgan Stanley

Maintains Overweight

Cigna target cut to $207 from $241 by Morgan Stanley

Maintains Overweight

Anthem target upped to $371 from $359 by Morgan Stanley

Maintains Overweight

Key events next week – healthcare

Noteworthy events during the week of July 14 – 20 for healthcare investors.
SUNDAY (7/14): Alzheimer’s Association International Conference, Los Angeles (5 days). ProMIS Neurosciences (OTCQB:ARFXF): Data on lead candidate PMN310. Cortexyme (NASDAQ:CRTX): Design rationale for Phase 2/3 study of COR388.
MONDAY (7/15): World Diabetes Congress, Rome (3 days). Oramed Pharmaceuticals (NASDAQ:ORMP): Two presentation on oral insulin.
Cytori Therapeutics (NASDAQ:CYTX): Webcast on new strategic direction.